| Literature DB >> 34158674 |
Christopher J A Warner1, Mauro Salinas2, David Zamorano-Sánchez2, Walter M Bray3, R Scott Lokey1,3, Fitnat H Yildiz2, Roger G Linington1,4.
Abstract
Although Gram-negative bacterial pathogens continue to impart a substantial burden on global healthcare systems, much remains to be understood about aspects of basic physiology in these organisms. In recent years, cyclic-diguanylate (c-di-GMP) has emerged as a key regulator of a number of important processes related to pathogenicity, including biofilm formation, motility and virulence. In an effort to discover chemical genetic probes for studying V. cholerae we have developed a new motility-based high-throughput screen to identify compounds that modulate c-di-GMP levels. Using this new screening platform, we tested a library of microbially-derived marine natural products extracts, leading to the discovery of the bioactive lipid (S)-sebastenoic acid. Evaluation of the effect of this new compound on bacterial motility, vpsL expression and biofilm formation implied that (S)-sebastenoic acid may alter phenotypes associated to c-di-GMP signaling in V. cholerae.Entities:
Keywords: Actinobacteria; High-throughput screening; Motility; Natural products; Vibrio cholerae
Year: 2017 PMID: 34158674 PMCID: PMC8216231 DOI: 10.1139/cjc-2017-0334
Source DB: PubMed Journal: Can J Chem ISSN: 0008-4042 Impact factor: 1.118